EverydayHealthLogo
Dr. Steven Foung, MD

Dr. Steven Foung, MD

Stanford, CA

44 Years of Experience

Accepting patients

    Who is Dr. Foung, Anatomic Pathologist & Clinical Pathologist in Stanford, CA?

    Dr. Steven Foung, MD is an Anatomic Pathologist & Clinical Pathologist, who primarily practices in Stanford, CA with 1 additional practice location. He has been practicing for over 44 years. Dr. Foung completed his residency at Stanford University Medical Center. Dr. Foung is fluent in English and Spanish, and is currently seeing new patients. To book an appointment or to confirm insurance options, please call Dr. Foung’s office at (650) 723-4000.

    Where did Dr. Foung go to medical school and complete their residency?

    • Residency: Stanford University Medical Center | University of California, San Francisco

    What languages does Dr. Foung speak?

    Dr. Foung and their clinical team can communicate with patients in the following languages:

    • English

    • Spanish

    Does Dr. Foung accept my insurance?

    Please contact Dr. Foung's office to confirm accepted insurance plans.

    Where is Dr. Foung's office located?

    Dr. Steven Foung's Primary Practice

    300 Pasteur Dr

    Stanford, CA 94305

    (650) 723-4000

    Get Directions

    Dr. Steven Foung's Practice 2

    3373 Hillview Ave

    Palo Alto, CA 94304

    Get Directions

    Recognitions

    Publications

    Structural basis of HCV neutralization by human monoclol antibodies resistant to viral

    PLoS pathogens, 2013

    Contrasting Roles of Mitogen-Activated Protein Kises in Cellular Entry

    JOURL OF VIROLOGY, 2013

    Characterization of Hepatitis C Virus Recombints with Chimeric E1

    JOURL OF VIROLOGY, 2013

    Cooperativity in Virus Neutralization by Human Monoclol Antibodies

    JOURL OF VIROLOGY, 2013

    Transient Activation of the PI3K-AKT Pathway by Hepatitis C Virus to Enhance Viral Entry

    JOURL OF BIOLOGICAL CHEMISTRY, 2012

    Toward a Hepatitis C Virus Vaccine

    JOURL OF VIROLOGY, 2012

    Mutations That Alter Use of Hepatitis C Virus Cell Entry Factors Mediate Escape From Neutralizing

    GASTROENTEROLOGY, 2012

    Human Monoclol Antibodies to a Novel Cluster of Con

    PLOS PATHOGENS, 2012

    Affinity Maturation to Improve Human Monoclol Antibody Neutralization Potency

    JOURL OF BIOLOGICAL CHEMISTRY, 2011

    Neutralizing Antibody Response to Hepatitis C Virus

    VIRUSES-BASEL, 2011

    Mapping a Region of Hepatitis C Virus E2 That Is Responsible

    JOURL OF VIROLOGY, 2011

    Comprehensive linker-scanning mutagenesis of the hepatitis C virus E1

    JOURL OF GENERAL VIROLOGY, 2011

    The Hepatitis C Virus E1 Glycoprotein Undergoes Productive Folding

    PLOS ONE, 2011

    The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV)

    JOURL OF GENERAL VIROLOGY, 2011

    Hepatitis C virus e2 protein ectodomain is essential for assembly of infectious virions.

    Intertiol jourl of hepatology, 2011

    Hepatitis C Virus Hypervariable Region 1 Modulates Receptor Interactions

    JOURL OF VIROLOGY, 2010

    Mutations within a Conserved Region of the Hepatitis C Virus E2 Glycoprotein That Influence Virus

    JOURL OF VIROLOGY, 2010

    Antigen-specific Proteolysis by Hybrid Antibodies Containing Promiscuous Proteolytic Light Chains

    JOURL OF BIOLOGICAL CHEMISTRY, 2009

    CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells

    JOURL OF GENERAL VIROLOGY, 2009

    In vitro selection of a neutralization-resistant hepatitis C virus escape mutant

    PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2008

    Hepatitis C virus (HCV)

    JOURL OF VIROLOGY, 2008

    A point mutation leading to hepatitis C virus escape from neutralization

    JOURL OF VIROLOGY, 2008

    Definition of a conserved immunodomint domain on hepatitis C virus E2 glycoprotein

    JOURL OF VIROLOGY, 2008

    Antibody-dependent enhancement of hepatitis C virus infection

    JOURL OF VIROLOGY, 2008

    Broadly neutralizing human monoclol antibodies to the hepatitis C virus E2 glycoprotein

    JOURL OF GENERAL VIROLOGY, 2008

    Structural elucidation of critical residues involved

    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2008

    Therapeutic control of hepatitis C virus: The role of neutralizing monoclol antibodies

    HUMAN ANTIBODY THERAPEUTICS FOR VIRAL DISEASE, 2008

    The neutralizing activity of anti

    JOURL OF VIROLOGY, 2007

    Immunogenic and functiol organization of hepatitis C virus

    JOURL OF VIROLOGY, 2007

    High density lipoprotein inhibits hepatitis C virus

    JOURL OF BIOLOGICAL CHEMISTRY, 2006

    Preclinical evaluation of two neutralizing human monoclol antibodies against hepatitis C virus

    JOURL OF VIROLOGY, 2006

    Hepatitis C virus induces toll-like receptor 4 expression

    JOURL OF VIROLOGY, 2006

    Alysis of a highly flexible conformatiol immunogenic domain a in hepatitis C virus E2

    JOURL OF VIROLOGY, 2005

    Folding and dimerization of hepatitis C virus E1 and E2 glycoproteins

    VIROLOGY, 2005

    Antibody light chain-catalyzed hydrolysis of a hepatitis C virus peptide

    BIOORGANIC & MEDICIL CHEMISTRY LETTERS, 2004

    Hepatitis C virus E2 has three immunogenic domains containing con

    JOURL OF VIROLOGY, 2004

    Human monoclol antibody to hepatitis C virus El glycoprotein that blocks virus attachment

    JOURL OF VIROLOGY, 2004

    Incomplete humoral immunity against hepatitis C virus is linked with distinct recognition of

    JOURL OF IMMUNOLOGY, 2004

    Characterization of functiol hepatitis C virus envelope glycoproteins

    JOURL OF VIROLOGY, 2004

    DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2

    JOURL OF BIOLOGICAL CHEMISTRY, 2003

    Recognition of tive hepatitis C virus E1E2 heterodimers by a human monoclol antibody

    JOURL OF VIROLOGY, 2003

    Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti

    VIROLOGY, 2002

    Epitope mapping of human monoclol antibodies recognizing con

    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002

    The B-cell receptor of a hepatitis C virus

    BLOOD, 2001

    Cross-reactivity and clinical impact of the antibody response to hepatitis C virus second envelope

    JOURL OF MEDICAL VIROLOGY, 2001

    V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal

    BLOOD, 2001

    Human monoclol antibodies that inhibit binding of hepatitis C virus E2 protein to CD81

    JOURL OF VIROLOGY, 2000

    The humoral immune response to human T

    JOURL OF VIROLOGY, 1999

    Large granular lymphocyte leukaemia occurring after rel transplantation

    BRITISH JOURL OF HAEMATOLOGY, 1998

    Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia

    BRITISH JOURL OF HAEMATOLOGY, 1998

    GBV-C/HGV: A new virus within the Flaviviridae and its clinical implications

    TRANSFUSION MEDICINE REVIEWS, 1998

    Experimental infection of chimpanzees with hepatitis G virus and genetic alysis of the virus

    JOURL OF INFECTIOUS DISEASES, 1998

    Seroreactivity to an envelope protein of human T-cell leukemia

    BLOOD, 1997

    Neutralizing human monoclol antibodies to conformatiol epitopes of human T

    JOURL OF VIROLOGY, 1997

    A source of glycosylated human T-cell lymphotropic virus type 1 envelope protein

    JOURL OF VIROLOGY, 1996

    Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent

    SCIENCE, 1996

    ENHANCED SPECIFICITY OF TRUNCATED TRANSMEMBRANE PROTEIN FOR SEROLOGIC CONFIRMATION OF HUMAN T

    JOURL OF CLINICAL MICROBIOLOGY, 1995

    DELINEATION OF AN IMMUNODOMINT AND HUMAN T-CELL LYMPHOTROPIC VIRUS

    BLOOD, 1995

    Stabilizing antibody secretion of human Epstein Barr virus-activated B

    Methods in molecular biology (Clifton, N.J.), 1995

    LOCALIZATION OF ANTIGENIC SITES ON HUMAN CYTOMEGALOVIRUS VIRION STRUCTURAL PROTEINS

    VIROLOGY, 1994

    IMMUNOGLOBULIN PROPHYLAXIS AGAINST HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-II IN RABBITS

    JOURL OF INFECTIOUS DISEASES, 1994

    AMPLIFICATION AND DETECTION OF A SINGLE-MOLECULE OF HUMAN-IMMUNODEFICIENCY-VIRUS R

    VIRUS GENES, 1993

    HUMAN T-LYMPHOTROPIC VIRUS TYPE-I/II IN LAKE LINDU VALLEY, CENTRAL SULAWESI, INDONESIA

    JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993

    ASSOCIATION OF (TROPICAL) ATAXIC NEUROPATHY WITH HTLV-II

    VIRUS RESEARCH, 1993

    ISOTYPIC AND IGG SUBCLASS RESTRICTION OF THE HUMORAL IMMUNE-RESPONSES TO HUMAN T

    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1993

    SPASTIC ATAXIA ASSOCIATED WITH HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-II INFECTION

    ANLS OF NEUROLOGY, 1993

    EVALUATION OF AN IMMUNOBLOT ASSAY FOR SEROLOGICAL CONFIRMATION AND DIFFERENTIATION OF HUMAN T

    JOURL OF CLINICAL MICROBIOLOGY, 1993

    NEUTRALIZING ANTIBODY TO VESICULAR STOMATITIS-VIRUS

    JAPANESE JOURL OF CANCER RESEARCH, 1993

    IMMUNE RESPONSIVENESS TO THE IMMUNODOMINT RECOMBINT ENVELOPE EPITOPES OF HUMAN T

    JOURL OF INFECTIOUS DISEASES, 1992

    CLONING AND ALYSIS OF A RECOMBINT ANTIGEN CONTAINING AN EPITOPE SPECIFIC FOR HUMAN T

    BLOOD, 1992

    SEROLOGIC CONFIRMATION OF SIMIAN T-LYMPHOTROPIC VIRUS TYPE

    JOURL OF CLINICAL MICROBIOLOGY, 1992

    ANTIBODIES TO HEPATITIS-C VIRUS IN LOW

    GASTROENTEROLOGY, 1991

    MODIFIED WESTERN-BLOT ASSAY FOR CONFIRMATION AND DIFFERENTIATION OF HUMAN T

    JOURL OF INFECTIOUS DISEASES, 1991

    Parameters to enhance human hybridoma formation with hypoosmolar electrofusion.

    Human antibodies and hybridomas, 1991

    HTLV-I-ASSOCIATED MYELOPATHY IN A CALIFORNIAN - DIAGNOSIS BY REACTIVITY TO A VIRAL RECOMBINT

    NEUROLOGY, 1991

    SIGNIFICANCE OF HUMAN T-LYMPHOTROPIC VIRUS TYPE

    VOX SANGUINIS, 1991

    DEVELOPMENT OF MICROFUSION TECHNIQUES TO GENERATE HUMAN HYBRIDOMAS

    JOURL OF IMMUNOLOGICAL METHODS, 1990

    EFFICIENT HYBRIDIZATION OF MOUSE-HUMAN CELL-LINES BY MEANS OF HYPOOSMOLAR ELECTROFUSION

    JOURL OF IMMUNOLOGICAL METHODS, 1990

    LOW INCIDENCE OF HTLV INFECTIONS IN RANDOM BLOOD-DONORS WITH INDETERMITE WESTERN-BLOT PATTERNS

    TRANSFUSION, 1990

    GENERATION OF A HUMAN HYBRIDOMA PRODUCING A PURE ANTI-HLA-A2 MONOCLOL-ANTIBODY

    HUMAN IMMUNOLOGY, 1990

    HUMAN MONOCLOL-ANTIBODIES TO HUMAN CYTOMEGALO-VIRUS

    JOURL OF INFECTIOUS DISEASES, 1989

    ELECTRIC FIELD-INDUCED CELL-FUSION AND HUMAN MONOCLOL-ANTIBODIES

    JOURL OF IMMUNOLOGICAL METHODS, 1989

    INITIAL IDENTIFICATION AND MAPPING OF DISTINCT RH0 (D) EPITOPES

    REVUE FRANCAISE DE TRANSFUSION ET IMMUNO-HEMATOLOGIE, 1988

    THE EFFICACY OF PLA1-NEGATIVE PLATELET TRANSFUSION THERAPY IN POSTTRANSFUSION PURPURA

    WESTERN JOURL OF MEDICINE, 1988

    HUMAN MONOCLOL-ANTIBODIES TO RH0(D)

    VOX SANGUINIS, 1987

    HUMAN MONOCLOL ANTI-T-CELL ANTIBODY FROM A PATIENT WITH JUVENILE RHEUMATOID-ARTHRITIS

    JOURL OF IMMUNOLOGY, 1987

    EARLY IMMUNE-RESPONSE IN HEALTHY AND IMMUNOCOMPROMISED SUBJECTS WITH PRIMARY VARICELLA

    JOURL OF INFECTIOUS DISEASES, 1986

    A MONOCLOL-ANTIBODY AGAINST HLA-A11 AND A24

    HUMAN IMMUNOLOGY, 1986

    A HUMAN MONOCLOL-ANTIBODY TO RHG

    VOX SANGUINIS, 1986

    GENERATION OF HUMAN MONOCLOL-ANTIBODIES BY FUSION OF EBV

    METHODS IN ENZYMOLOGY, 1986

    HUMAN MONOCLOL-ANTIBODIES NEUTRALIZING VARICELLA-ZOSTER VIRUS

    JOURL OF INFECTIOUS DISEASES, 1985

    HUMAN MONOCLOL-ANTIBODIES AGAINST GROUP-A RED BLOOD-CELLS

    VOX SANGUINIS, 1985

    A NEW APPROACH TO THE DIAGNOSIS OF ACTIVE RH0(D) IMMUNIZATION IN PASSIVELY IMMUNIZED PREGNT-WOMEN

    VOX SANGUINIS, 1985

    RESCUE OF HUMAN MONOCLOL-ANTIBODY PRODUCTION FROM AN EBV

    JOURL OF IMMUNOLOGICAL METHODS, 1984

    MONOCLOL-ANTIBODY (B27M2) SUBDIVIDING HLA-B27

    HUMAN IMMUNOLOGY, 1982

    PRODUCTION OF FUNCTIOL HUMAN T-T-HYBRIDOMAS IN SELECTION MEDIUM LACKING AMINOPTERIN AND THYMIDINE

    PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 1982

    EOSINOPHILIA IN CHILDREN

    PEDIATRIC ANLS, 1979

    EFFECTS OF STARVATION AND REFEEDING ON MUSCLE PROTEIN-SYNTHESIS AND CATABOLISM IN YOUNG RAT

    JOURL OF NUTRITION, 1978

    What is Dr. Foung's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.

    Dr. Foung's National Provider Identifier (NPI) number is 1548325152.

    What common questions do patients ask about Dr. Foung?

    Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Foung

    What is Dr. Steven Foung's specialty?

    Dr. Foung is a Anatomic Pathologist & Clinical Pathologist near Stanford, CA. A pathologist focuses on the causes and nature of diseases, contributing to diagnosis, prognosis, and treatment by applying knowledge from biological, chemical, and physical sciences in the laboratory. They utilize microscopic examinations of tissue specimens, cells, and body fluids, along with clinical laboratory tests on fluids and secretions, to diagnose, exclude, or monitor diseases. Contact Dr. Foung to book an appointment today.

    Is this Dr. Steven Foung affiliated with a ranked Castle Connolly Top Hospital?

    No, Foung is not affiliated with a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals

    Where can I learn more about Anatomic Pathologist & Clinical Pathologist?

    Explore Anatomic Pathologist & Clinical Pathologist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.

    Is Steven Foung accepting new patients in Stanford, CA?

    Yes, Dr. Steven Foung is accepting new patients at this time.

    Does Dr. Steven Foung offer online booking?

    Please contact Dr. Foung's office at (650) 723-4000 for information about online booking, telehealth, or to schedule an appointment.

    How can I make an appointment with Steven Foung?

    Please contact Dr. Foung's office at (650) 723-4000 for information regarding telehealth appointment availability or for scheduling assistance.

    Other Anatomic Pathologist & Clinical Pathologist Near Stanford, CA

    BH

    Anatomic Pathologist & Clinical Pathologist

    acceptingPatients-iconAccepting patients
    Stanford, CA
    MR

    Anatomic Pathologist & Clinical Pathologist

    acceptingPatients-iconAccepting patients
    Stanford, CA
    AS

    Anatomic Pathologist & Clinical Pathologist

    acceptingPatients-iconAccepting patients
    Stanford, CA
    See All Specialists

    Doctors by Category

    Specialists